This was the stock's fourth consecutive day of losses.

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...

After hours: February 13 at 4:20:00 PM EST Loading Chart for HSIC ...

The National Association of Wholesaler-Distributors (NAW) announced Henry Schein Chairman and CEO Stanley Bergman will receive its Dirk Van Dongen Lifetime Achievement Award. The Award was named in ...

After hours: February 12 at 5:52:41 PM EST ...

Eli Lilly is partnering with Rimidi on a diabetes management tool, with similar approaches undertaken at Sanofi and Health2Sync as well as Novo Nordisk and Abbott.